MedTrace Logo

(DIS)AGreement of Relatives Regarding Ethical End-of-life Decisions in ICU.

NCT05768906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 429

Last updated 2025-09-03

No results posted yet for this study

Summary

In the ICU, the vast majority of patients die following a life-sustaining therapies (LST) limitation decision. Most often, the patient is not able to express himself and has not made his wishes known beforehand, for example in the form of advance directives. The "relatives" are then the only recourse to state the patient's wishes, without any guarantee that they are aware of them. In France, the final decision is made by the physician (or the medical team) who is responsible for it. In this context, disagreements and even real legal conflicts on LST limitation decisions between relatives and physicians seem to be more and more frequent. To our knowledge, few data exist on the frequency of these disagreements over LST limitation decisions.

The main objective of this study is to evaluate the frequency of disagreements between relatives and physicians over LST limitation decisions in adult intensive care.

Conditions

  • Cessation of Treatment
  • End of Life

Interventions

OTHER

observational

Observation of disagreements and even real legal conflicts on life-sustaining therapies limitation decisions between relatives and physicians

Sponsors & Collaborators

  • Société Française d'Anesthésie et de Réanimation

    lead OTHER

Principal Investigators

  • Mikhael Giabicani, MD · Hôpital Beaujon - 100 boulevard du Général Leclerc - 92110 Clichy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768906 on ClinicalTrials.gov